Teleflex Incorporated (TFX)
NYSE: TFXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
TFX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.27B
- Forward P/E
- 11.37
- EPS (TTM)
- -$8.48
- Dividend yield
- 1.09% ($1.36)
- Ex-dividend date
- Aug 14, 2026
- 52-week range
- 100.18 – 145.00
- Day range
- 122.88 – 126.84
- Volume / Avg
- 928.30K / 644.67K
- Beta
- —
- Shares outstanding
- 42.37M
- Next earnings
- Nov 5, 2026
52-week range
TFX stock today
Shares of Teleflex (TFX) finished lower on Oct 7 at $124.48, a drop of 0.21% or $0.26 per share, versus the S&P 500's 0.22% decline. At this level, TFX sits in the middle of its 52-week range of $100.18 to $145.00: 14.2% below the high, set on Aug 6, 2026 and 24.3% above the low. TFX is up 2.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 1.9%.
Teleflex has posted a net loss over the last twelve months (EPS of -$8.48), so its P/E ratio is not meaningful. Teleflex's next earnings report is expected on Nov 5, 2026. Teleflex pays an annual dividend of $1.36 per share, a 1.09% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Teleflex
Company profileTeleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Jason Weidman
- Headquarters
- Wayne, PA
- Employees
- 15,500
- Website
- teleflex.com
Financial highlights
Full financialsIn fiscal 2025, Teleflex generated $1.99 billion in revenue, up 17.2% from fiscal 2024. Teleflex reported a net loss of $905.6 million, compared with net income of $69.7 million a year earlier. Gross margin was 56.2% (down from 61.0%) and operating margin 5.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.99B | $1.70B | $1.71B | $2.79B | $2.81B |
| Growth | +17.25% | -0.75% | -38.65% | -0.66% | +10.74% |
| Net income | $-905.64M | $69.67M | $356.33M | $363.14M | $485.37M |
| EPS (diluted) | $-20.25 | $1.48 | $7.53 | $7.68 | $10.23 |
Analyst forecast
ForecastConsensus (13 analysts)
buy
Avg. price target
$154.73+24.30%
- Strong buy 4
- Buy 2
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $1.92
- Last reported (Q2 2026)
- Aug 6, 2026
- EPS actual vs est.
- $2.28 vs —
Dividends
Dividend history- Annual dividend
- $1.36
- Dividend yield
- 1.09%
- Last payment
- $0.34
- Ex-dividend date
- Aug 14, 2026
TFX news
All TFX news- Boston Scientific's MedSurg Diversification Bolsters Growth ProspectsNasdaqBSX, MDT, TFX
- Illumina Stock Surges 94.9% YTD: What's Behind the Rally?NasdaqILMN, TFX, GMED, VCYT
- Should You Continue to Hold IDXX Stock in Your Portfolio?NasdaqIDXX, TFX, GMED, VCYT
- IDEXX Stock Gains Following the Acquisition of CoVetNasdaqIDXX, TFX, GMED, VCYT
- Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?NasdaqTFX, BSX, BDX
- Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?NasdaqIDXX, TFX, GMED, VCYT
- Should You Hold Edwards Lifesciences Stock in Your Portfolio?NasdaqEW, TFX, GMED, VCYT
Teleflex peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STVNStevanato Group S.p.A. | 19.44 | -2.11% | $5.31B | vs TFX |
| MMEDMiniMed Group Inc. | 19.11 | -2.70% | $5.38B | vs TFX |
| MMSIMerit Medical Systems Inc. | 85.09 | +0.15% | $5.08B | vs TFX |
| HAEHaemonetics Corporation | 101.71 | -1.75% | $4.63B | vs TFX |
| HTFLHeartflow Inc. | 49.36 | -2.62% | $4.29B | vs TFX |
| ICUIICU Medical Inc. | 156.03 | -2.32% | $3.90B | vs TFX |
| NVSTEnvista Holdings Corporation | 23.04 | -0.99% | $3.70B | vs TFX |
| PLSEPulse Biosciences Inc | 49.09 | -1.33% | $3.50B | vs TFX |
Indexes, lists and sector
Appears in lists
Teleflex stock FAQ
What is Teleflex's stock price today?
TFX last traded at $124.48 as of Oct 7, 4:00 PM EDT, down 0.21% on the day. Prices are delayed at least 15 minutes.
Does Teleflex pay a dividend?
Yes. Teleflex pays $1.36 per share annually, a 1.09% yield. The most recent dividend of $0.34 had an ex-dividend date of Aug 14, 2026.
When is Teleflex's next earnings date?
Teleflex is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $1.92.
Who is Teleflex's CEO?
Mr. Jason Weidman is the chief executive officer of Teleflex Incorporated, which has about 15,500 employees.
Has TFX ever split its stock?
Yes. The most recent TFX stock split was a 2-for-1 split on Jun 17, 1997, one of 5 splits on record.
What is the TFX 52-week high?
The 52-week high for TFX is $145.00 and the 52-week low is $100.18. The stock is currently 14.2% below its high.